Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Invested Capital (2019 - 2025)

Biodesix's Invested Capital history spans 7 years, with the latest figure at -$2.5 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 111.81% year-over-year to -$2.5 million; the TTM value through Dec 2025 reached -$2.5 million, down 111.81%, while the annual FY2025 figure was -$2.5 million, 111.81% down from the prior year.
  • Invested Capital reached -$2.5 million in Q4 2025 per BDSX's latest filing, down from -$1.7 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $42.1 million in Q2 2024 to a low of -$2.5 million in Q4 2025.
  • Average Invested Capital over 5 years is $19.8 million, with a median of $19.4 million recorded in 2023.
  • Peak YoY movement for Invested Capital: soared 456.26% in 2024, then tumbled 111.81% in 2025.
  • A 5-year view of Invested Capital shows it stood at $37.5 million in 2021, then fell by 17.45% to $30.9 million in 2022, then dropped by 14.57% to $26.4 million in 2023, then dropped by 21.03% to $20.9 million in 2024, then crashed by 111.81% to -$2.5 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Invested Capital are -$2.5 million (Q4 2025), -$1.7 million (Q3 2025), and $1.1 million (Q2 2025).